Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Eric Andreas Rutten"'
Autor:
Ilona Barbara Csordás, Eric Andreas Rutten, Tünde Szatmári, Prabal Subedi, Lourdes Cruz-Garcia, Dávid Kis, Bálint Jezsó, Christine von Toerne, Martina Forgács, Géza Sáfrány, Soile Tapio, Christophe Badie, Katalin Lumniczky
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 10, p 8607 (2023)
Extracellular vesicles (EVs), through their cargo, are important mediators of bystander responses in the irradiated bone marrow (BM). MiRNAs carried by EVs can potentially alter cellular pathways in EV-recipient cells by regulating their protein cont
Externí odkaz:
https://doaj.org/article/da32caad9291454fa78534468cedd68c
Autor:
Dmitry Klokov, Kimberly Applegate, Christophe Badie, Dag Anders Brede, Fieke Dekkers, Melis Karabulutoglu, Yevgeniya Le, Eric Andreas Rutten, Katalin Lumniczky, Maria Gomolka
Publikováno v:
International Journal of Radiation Biology
International Journal of Radiation Biology, 2023, 98 (12), pp.1802-1815. ⟨10.1080/09553002.2022.2117873⟩
International Journal of Radiation Biology, 2023, 98 (12), pp.1802-1815. ⟨10.1080/09553002.2022.2117873⟩
International audience; Purpose: The concept of the adverse outcome pathway (AOP) has recently gained significant attention as to its potential for incorporation of mechanistic biological information into the assessment of adverse health outcomes fol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::960ae846cf5f78ac19a8947a0417c2f0
https://irsn.hal.science/irsn-04021149
https://irsn.hal.science/irsn-04021149
Autor:
Eric Andreas Rutten, Christophe Badie
Publikováno v:
Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 603, p 603 (2021)
Journal of Personalized Medicine, Vol 11, Iss 603, p 603 (2021)
Humans have learned to harness the power of radiation for therapeutic ends, with 50% of all patients diagnosed with cancer undergoing radiotherapy as part of their treatment [...]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1b411b6a433a439da27cd4854e9cc07
https://pubmed.ncbi.nlm.nih.gov/34202274
https://pubmed.ncbi.nlm.nih.gov/34202274
Autor:
Udo S. Gaipl, Eric Andreas Rutten, Serge M. Candéias, Géza Sáfrány, Benjamin Frey, Enikő Kis, Katalin Lumniczky, Zsuzsa S Kocsis, Zsolt Jurányi, Enikő Noémi Bogdándi, Katalin Balázs, Christophe Badie, Piotr Widlak, Lourdes Cruz Garcia, Iwona Domińczyk
Publikováno v:
Cancers
Cancers, 2019, 11 (9), pp.1324. ⟨10.3390/cancers11091324⟩
Volume 11
Issue 9
Cancers, Vol 11, Iss 9, p 1324 (2019)
Cancers, MDPI, 2019, 11 (9), pp.1324. ⟨10.3390/cancers11091324⟩
Cancers, 2019, 11 (9), pp.1324. ⟨10.3390/cancers11091324⟩
Volume 11
Issue 9
Cancers, Vol 11, Iss 9, p 1324 (2019)
Cancers, MDPI, 2019, 11 (9), pp.1324. ⟨10.3390/cancers11091324⟩
International audience; Though radiotherapy is a local therapy, it has systemic effects mainly influencing immune and inflammation processes. This has important consequences in the long-term prognosis and therapy individualization. Our objective was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6d7a0261394c3edae1f21d6afaf917a
https://hal.science/hal-02296009
https://hal.science/hal-02296009